Cochlear Valuation

Is COH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: COH (A$293.02) is trading above our estimate of fair value (A$229.77)

Significantly Below Fair Value: COH is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for COH?

Key metric: As COH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for COH. This is calculated by dividing COH's market cap by their current earnings.
What is COH's PE Ratio?
PE Ratio53.7x
EarningsAU$356.80m
Market CapAU$19.50b

Price to Earnings Ratio vs Peers

How does COH's PE Ratio compare to its peers?

The above table shows the PE ratio for COH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28x
SHL Sonic Healthcare
26x11.0%AU$13.3b
RHC Ramsay Health Care
34.1x19.3%AU$8.7b
AHC Austco Healthcare
12.3xn/aAU$87.4m
ANN Ansell
39.5x22.8%AU$4.7b
COH Cochlear
53.7x11.7%AU$19.5b

Price-To-Earnings vs Peers: COH is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the peer average (28x).


Price to Earnings Ratio vs Industry

How does COH's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

10 CompaniesPrice / EarningsEstimated GrowthMarket Cap
COH 53.7xIndustry Avg. 28.0xNo. of Companies50PE020406080100+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: COH is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the Global Medical Equipment industry average (28x).


Price to Earnings Ratio vs Fair Ratio

What is COH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio53.7x
Fair PE Ratio36x

Price-To-Earnings vs Fair Ratio: COH is expensive based on its Price-To-Earnings Ratio (53.7x) compared to the estimated Fair Price-To-Earnings Ratio (36x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$293.02
AU$294.59
+0.5%
10.6%AU$345.00AU$225.00n/a14
Nov ’25AU$285.05
AU$290.87
+2.0%
10.1%AU$345.00AU$225.00n/a14
Oct ’25AU$291.42
AU$287.37
-1.4%
10.7%AU$345.00AU$225.00n/a14
Sep ’25AU$300.37
AU$283.49
-5.6%
11.7%AU$345.00AU$225.00n/a15
Aug ’25AU$344.57
AU$287.17
-16.7%
13.8%AU$365.00AU$220.00n/a15
Jul ’25AU$322.56
AU$280.94
-12.9%
13.2%AU$365.00AU$220.00n/a16
Jun ’25AU$322.56
AU$280.94
-12.9%
13.2%AU$365.00AU$220.00n/a16
May ’25AU$317.17
AU$280.94
-11.4%
13.2%AU$365.00AU$220.00n/a16
Apr ’25AU$337.52
AU$282.20
-16.4%
12.9%AU$365.00AU$220.00n/a17
Mar ’25AU$336.50
AU$281.02
-16.5%
13.5%AU$365.00AU$220.00n/a17
Feb ’25AU$304.87
AU$254.43
-16.5%
13.1%AU$318.46AU$200.00n/a16
Jan ’25AU$298.67
AU$251.45
-15.8%
12.2%AU$318.46AU$200.00n/a17
Dec ’24AU$272.29
AU$241.65
-11.3%
10.6%AU$295.00AU$197.78n/a18
Nov ’24AU$244.27
AU$239.49
-2.0%
9.3%AU$280.00AU$197.78AU$285.0518
Oct ’24AU$255.32
AU$238.98
-6.4%
9.6%AU$280.00AU$197.78AU$291.4218
Sep ’24AU$268.50
AU$238.25
-11.3%
9.8%AU$280.00AU$190.00AU$300.3719
Aug ’24AU$238.87
AU$226.67
-5.1%
9.1%AU$265.00AU$190.00AU$344.5719
Jul ’24AU$229.07
AU$225.49
-1.6%
9.1%AU$265.00AU$190.00AU$322.5619
Jun ’24AU$248.25
AU$225.20
-9.3%
9.2%AU$265.00AU$190.00AU$322.5619
May ’24AU$246.34
AU$224.13
-9.0%
8.9%AU$265.00AU$190.00AU$317.1716
Apr ’24AU$236.69
AU$224.13
-5.3%
8.9%AU$265.00AU$190.00AU$337.5216
Mar ’24AU$223.41
AU$222.06
-0.6%
8.0%AU$250.63AU$190.00AU$336.5017
Feb ’24AU$212.50
AU$216.05
+1.7%
9.9%AU$247.00AU$173.00AU$304.8716
Jan ’24AU$204.12
AU$215.68
+5.7%
10.4%AU$247.00AU$167.00AU$298.6716
Dec ’23AU$213.00
AU$215.62
+1.2%
10.4%AU$247.00AU$167.00AU$272.2916
Nov ’23AU$200.66
AU$214.70
+7.0%
10.2%AU$247.00AU$167.00AU$244.2717

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies